Organizational readiness and engagement of community oncology practices in implementing tobacco use assessment and treatment

项目总结/摘要 在美国，吸烟仍然是可预防的过早疾病、残疾和死亡的主要原因。 States.烟草使用评估和治疗对癌症诊断的个人很重要，因为 持续吸烟会增加疾病负担，并导致负面的治疗结果。虽然 国家综合癌症网络（NCCN）建议进行基于证据的烟草使用评估， 治疗，在癌症护理的背景下戒烟的实际交付一直不一致。几 研究已经检验了组织水平的因素如何影响NCCN吸烟指南的采用 停止肿瘤学实践。基于社区的肿瘤学网络服务于不同人群，包括 农村、经济/社会弱势群体、少数种族和族裔以及资源匮乏的社区。我们 建议加强父母补助金的临床试验，“在美国实施虚拟烟草治疗”。 社区肿瘤学实践”（R 01 CA 214427; MPI Dr. Park和Dr. Ostroff）通过：1）检查 影响在癌症护理环境中采用烟草治疗干预措施的组织背景;以及 2)确定战略，以促进在NCORP中实施烟草使用评估和治疗 癌症社区研究中心和少数民族/服务不足的社区研究中心入组了母R 01试验。 定量研究方法将被用来探讨组织准备之间的关联， 在NCORP实施烟草使用评估和治疗以及癌症护理提供能力 社区肿瘤学实践。使用混合方法的方法，我们将评估子联盟级别 参与，评估社区参与研究（CEnR）的障碍和促进因素，并确定潜在的 实施策略以改善社区采用烟草使用评估和治疗 肿瘤学环境，重点是了解参与SSS 2.0的NCORP研究中心之间的差异 审判这个项目的意义在于它对有关语境因素的有限知识的贡献 影响社区肿瘤学环境中烟草使用评估和治疗的采用。这 该项目还将确定如何最好地参与社区肿瘤学子分支机构，并为以下战略提供信息： 改善社区肿瘤学实践中戒烟的采用和整合。调查结果将告知 设计计划中的大规模第三类混合执行试验，以测试各种执行情况， 制定烟草使用记录系统和改善烟草使用的战略 在社区肿瘤学环境中进行评估和治疗。

PROJECT SUMMARY/ABSTRACT Smoking remains a leading cause of preventable premature disease, disability, and death in the United States. Tobacco use assessment and treatment is important for individuals with cancer diagnoses, because persistent smoking can increase illness burden and contribute to negative treatment outcomes. Although the National Comprehensive Cancer Network (NCCN) recommends evidence-based tobacco use assessment and treatment, the actual delivery of smoking cessation in the context of cancer care has been inconsistent. Few studies have examined how organizational level factors influence the adoption of NCCN guidelines for smoking cessation in oncology practices. Community based oncology networks serve diverse populations including rural, economically/socially disadvantaged, racial and ethnic minorities, and low-resourced communities. We propose to enhance the clinical trial for the parent grant, “Implementing A Virtual Tobacco Treatment in Community Oncology Practices” (R01CA214427; MPIs Dr. Park and Dr. Ostroff) by: 1) examining organizational contexts that influence adoption of tobacco treatment interventions in cancer care settings; and 2) identifying strategies to facilitate implementation of tobacco use assessment and treatment in NCORP cancer Community Sites and Minority/Underserved Community Sites enrolled in the parent R01 trial. Quantitative research methods will be used to explore the association between organizational readiness to implement tobacco use assessment and treatment and the capacity for cancer care delivery in NCORP community oncology practices. Using a mixed methods approach, we will evaluate sub affiliate level engagement, assess barriers and facilitators to community-engaged research (CEnR), and identify potential implementation strategies to improve adoption of tobacco use assessment and treatment in community oncology settings with a focus on understanding variation among the NCORP sites participating in the SSS 2.0 trial. The significance of this project is its contribution to the limited knowledge about contextual factors influencing the adoption of tobacco use assessment and treatment in community oncology settings. This project will also identify how best to engage community oncology sub affiliates and inform strategies for improving adoption and integration of smoking cessation in community oncology practices. Findings will inform the design of a planned large-scale type III hybrid implementation trial that will test various implementation strategies for developing systems for tobacco use documentation and improving adoption of tobacco use assessment and treatment in community oncology settings.